Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Stockholders equity, Beginning balance at Dec. 31, 2022	$ 2	$ 199,492	$ (35)	$ (161)	$ (150,266)	$ 49,032
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2022	23,312,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon stock option exercises		1,496				$ 1,496
Issuance of common stock upon stock option exercises (in shares)	1,264,899					1,264,899
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs	$ 2	46,501				$ 46,503
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs (in shares)	17,810,000
Stock-based compensation		3,051				3,051
Vesting of restricted common stock		1				1
Vesting of restricted common stock (in shares)	3,946
Vesting of restricted stock units, net of withholding			(22)			(22)
Vesting of restricted stock units, net of withholding (in shares)	23,367
Unrealized gain on marketable securities				160		160
Net Income (Loss)					(37,805)	(37,805)
Stockholders equity, Ending balance at Sep. 30, 2023	$ 4	250,541	(57)	(1)	(188,071)	62,416
Stockholders equity, Ending balance (in shares) at Sep. 30, 2023	42,414,741
Stockholders equity, Beginning balance at Jun. 30, 2023	$ 4	249,668	(54)	(2)	(177,435)	72,181
Stockholders equity, Beginning balance (in shares) at Jun. 30, 2023	42,381,952
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon stock option exercises		30				30
Issuance of common stock upon stock option exercises (in shares)	25,000
Stock-based compensation		843				843
Vesting of restricted stock units, net of withholding			(3)			(3)
Vesting of restricted stock units, net of withholding (in shares)	7,789
Unrealized gain on marketable securities				1		1
Net Income (Loss)					(10,636)	(10,636)
Stockholders equity, Ending balance at Sep. 30, 2023	$ 4	250,541	(57)	(1)	(188,071)	62,416
Stockholders equity, Ending balance (in shares) at Sep. 30, 2023	42,414,741
Stockholders equity, Beginning balance at Dec. 31, 2023	$ 4	250,825	(59)	9	(195,970)	54,809
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2023	42,422,531
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon at-the-market offering, net of issuance costs	$ 1	44,206				44,207
Issuance of common stock upon at-the-market offering, net of issuance costs (in shares)	11,625,295
Issuance of common stock upon stock option exercises		499				$ 499
Issuance of common stock upon stock option exercises (in shares)	379,425					379,425
Issuance of common stock upon exercise of common warrants		450				$ 450
Issuance of common stock upon exercise of common warrants (in shares)	200,000
Issuance of warrants upon amendment of debt facility		261				261
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs	$ 1	(1)
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs (in shares)	4,439,836
Stock-based compensation		3,103				3,103
Vesting of restricted stock units, net of withholding			(44)			(44)
Vesting of restricted stock units, net of withholding (in shares)	51,968
Unrealized gain on marketable securities				119		119
Net Income (Loss)					(34,049)	(34,049)
Stockholders equity, Ending balance at Sep. 30, 2024	$ 6	299,343	(103)	128	(230,019)	69,355
Stockholders equity, Ending balance (in shares) at Sep. 30, 2024	59,119,055
Stockholders equity, Beginning balance at Jun. 30, 2024	$ 5	298,178	(101)	(26)	(217,138)	80,918
Stockholders equity, Beginning balance (in shares) at Jun. 30, 2024	54,654,495
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon stock option exercises		12				12
Issuance of common stock upon stock option exercises (in shares)	12,478
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs	$ 1	(1)
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs (in shares)	4,439,836
Stock-based compensation		1,154				1,154
Vesting of restricted stock units, net of withholding			(2)			(2)
Vesting of restricted stock units, net of withholding (in shares)	12,246
Unrealized gain on marketable securities				154		154
Net Income (Loss)					(12,881)	(12,881)
Stockholders equity, Ending balance at Sep. 30, 2024	$ 6	$ 299,343	$ (103)	$ 128	$ (230,019)	$ 69,355
Stockholders equity, Ending balance (in shares) at Sep. 30, 2024	59,119,055